COMMUNIQUÉS West-GlobeNewswire

Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
15/05/2025
Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) [...]
Best Delta 8 Gummies For Euphoria by Candy Cloud in 2025
15/05/2025
LOS ANGELES, May 15, 2025 (GLOBE NEWSWIRE) -- Search interest for Delta-8 THC has grown over 800% since 2020, and gummies dominate those queries. According to Google Trends and retail data, gummies now outpace [...]
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
15/05/2025
KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today [...]
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
15/05/2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug [...]
NovaaLab Under Review: Best At-Home Red Light Therapy Products for Healing Pain & Recovery Support
15/05/2025
Explore NovaaLab’s FDA-cleared red light therapy devices, supported by clinical studies, and designed to help reduce pain, improve recovery, and support wellness — all from the comfort of home. Salt Lake City, May 14, [...]
Audien Atom Hearing Aid Under Review: The Audien Pro & Atom One OTC Hearing Devices for Crystal Clear Sound
15/05/2025
Exploring how Audien's OTC hearing aids—Atom One and Pro 2—are transforming hearing accessibility with invisible designs, crystal clear sound, and prescription-free convenience for adults with mild to moderate hearing [...]
Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results
14/05/2025
CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced [...]
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
14/05/2025
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Exemption (IDE) [...]
Precipio Announces its Q1-2025 Financial Results
14/05/2025
Conference call to follow tomorrow, May 15 at 5 PM EST NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , filed its 10-Q report today. The following [...]
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
14/05/2025
Correction: Time of BofA Conference SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that [...]
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
14/05/2025
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General and Special Meeting of [...]
SS Innovations Reports First Quarter 2025 Financial Results
14/05/2025
Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 FORT LAUDERDALE, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- SS [...]
Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report
14/05/2025
NOVATO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2024 Impact Report today, which covers the company’s approach to corporate responsibility. The report [...]
Jasper Therapeutics to Present at Upcoming Investor Conferences
14/05/2025
REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
14/05/2025
Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; [...]
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
14/05/2025
DEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights
14/05/2025
Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experience Announced selection of IL15-superagonist as first payload to be delivered into tumors with [...]
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results
14/05/2025
FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial [...]
FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update
14/05/2025
Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third quarter of 2025 [...]

Pages